Health Care Technology · Nasdaq

WAYWaystar Holding Corp.

Last close
$27.99 -0.5%
52-week range
$17.26 to $37.51
Market cap
$5.39B
Next earnings
Not scheduled

Fiscal 2025 at a glance

Revenue
$1.10B
+16% vs FY24
Net income
$112M
+686% vs FY24
Free cash flow
$283M
+99% vs FY24
Net cash
-$1.39B
Cash $86.2M, debt $1.47B

Stock price

+35% since Jun 2024

Valuation vs its own history since 2024

Below its median since 2024 on all 3 multiples

Where each multiple sits today inside its own range since 2024, measured at every quarter end. The thin tick is the median.

P/E, trailing
40.4x
n/a: Not enough history
Price / sales
4.3x
3.3x7.3x
40th percentile, below its median of 5.6x
EV / EBITDA
14.9x
12.2x23.5x
40th percentile, below its median of 20.0x
Price / free cash flow
20.4x
16.0x1,053x
30th percentile, below its median of 25.4x

Key statistics

Trailing 12 months unless noted, through the quarter ending 2026-09-30. Every figure carries its unit.

Valuation

P/E
40.4x
Earnings yield
2.5%
Price / sales
4.3x
Price / book
1.3x
Price / operating cash flow
17.1x
EV / EBITDA
14.9x
EV / sales
5.2x
Free cash flow yield
4.9%

Profitability

Gross margin
69.4%
Operating margin
21.9%
Net margin
10.7%
Return on equity
3.3%
Return on capital
3.5%

Growth per year

Revenue, 3 years
+16.0%
Revenue, 5 years
n/aLess than 5 years of history
EPS, 3 years
n/aNot meaningful (a loss in the window)

Balance sheet

Cash and investments
$277M
Total debt
$1.46B
Net cash
-$1.19B
Debt / equity
0.36x
Current ratio
2.10x

Shares and dividend

Shares outstanding
192M
Share count, 5 years
n/aLess than 5 years of history
Beta, 1 year
0.55
Dividend yield
n/a
Dividend per share, TTM
n/a
Payout ratio
n/a

n/a: No dividend

Every year we have of the business

Last 14 quarters, fiscal 2022 to 2025 and after. Hover a bar for its quarter.

Revenue and net incomeLatest quarter $326M
RevenueNet income
Gross profitLatest quarter $226M
EBITDALatest quarter $103M
Margins70 / 19 / 10%
GrossOperatingNet
Earnings per shareLatest quarter $0.16
Cash flowLatest quarter $104M
OperatingCapexFree
Cash vs debtLatest quarter $277M
Cash and investmentsTotal debt
P/E historyNow 40.4x
P/E
P/S historyNow 4.3x
P/S, median 5.6x dashed

Where the revenue comes from

Subscription and Circulation went from 52% to 51% of revenue in 3 years

Share of revenue by product line, fiscal 2022 to 2025, as reported in the 10-K.

Subscription and CirculationVolume Based RevenueImplementation Services and Other Revenue
FY22
52%48%
$705M
FY23
51%49%
$791M
FY24
49%51%
$944M
FY25
51%49%
$1.10B
Fiscal 2025 by product line
Product lineRevenueSharevs FY24
Subscription and Circulation$558M50.8%+22%
Volume Based Revenue$535M48.6%+11%
Implementation Services and Other Revenue$6.12M0.6%+8%

Health Care Technology peers

The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.

CompanyMarket capRevenue growth Operating marginP/EP/SP/E vs own history
VEEV Veeva Systems Inc $48.8B +16% 29.9%49.4x14.1x 8th percentile
DOCS Doximity, Inc. $5.95B +6% 26.3%46.4x9.0x 36th percentile
WAY Waystar Holding Corp. $5.39B +21% 21.9%40.4x4.3x Not enough history
SDGR Schrodinger, Inc. $1.86B +5% -49.6%No earnings6.9x No earnings

The company

Sector
Health Care
Industry
Health Care Technology
Headquarters
Lehi, UT
Fiscal year ends
December

Around the numbers

What the rest of EdgeStacker knows about WAY.

Next report

No confirmed report date in the next 95 days yet.

Open the Earnings Hub
Big funds, latest 13F

Held by 124 active funds. Crowd level: crowded.

Open the Smart money tab